Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lyell Immunopharma, Inc.

NASDAQ: LYEL · Life Sciences · 5 alerts · CIK 1806952

Share price
$14.65Close, Nov 16
Market cap
$360M
Shares outstanding
24.59MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lyell Immunopharma, Inc. filings on SEC EDGAR ↗

5:36 PM ET Form 4
Insider Buying

Lyell Immunopharma Insider ARCH Venture Partners IX LLC Buys $25M of Stock

ARCH Venture Partners IX LLC bought 2,321,262 shares of Lyell Immunopharma, Inc. at $10.77 a share, worth $25M in total on Nov 4, 2026. Shares held after the trade: 3,747,790 (+162.7%).

Value
$25M
Shares
2,321,262
Price
$10.77
Holding change
+162.7%
Trade date
Nov 4, 2026
5:34 PM ET Form 4
Insider Buying

Lyell Immunopharma Insider ARCH Venture Fund XIII L.P. Buys $25M of Stock

ARCH Venture Fund XIII L.P. bought 2,321,262 shares of Lyell Immunopharma, Inc. at $10.77 a share, worth $25M in total on Nov 4, 2026. Shares held after the trade: 3,747,790 (+162.7%).

Value
$25M
Shares
2,321,262
Price
$10.77
Holding change
+162.7%
Trade date
Nov 4, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.